FDA Seeks Comment on Advisory Committee Information Collection

The Food and Drug Administration (FDA) is requesting public comment on its proposed collection of information related to advisory committee activities. This notice initiates a comment period for stakeholders to provide feedback on the agency's information collection requests concerning these committees.

FDA Proposed Collection for Animal Drug User Fees

The Food and Drug Administration (FDA) has published a proposed collection of information regarding animal drug and animal generic drug user fees. This notice initiates a public comment period for the proposed reporting requirements associated with these user fees.

FDA National Priority Voucher Pilot Program Public Hearing Request

The FDA is announcing a public hearing regarding its National Priority Voucher Pilot Program. The hearing will be held on June 12, 2026, and is intended to gather public input on the program. Registration details and requests for participation are available on the FDA website.

NFA Clarifies Affiliate Lending Rules for Commodity Pool Operators

The National Futures Association (NFA) has adopted amendments to Rule 2-45, effective March 16, 2026, to clarify affiliate lending arrangements for commodity pool operators (CPOs). These changes expand circumstances under which CPOs may lend pool assets to affiliates, introducing new compliance and recordkeeping obligations, particularly for large, regulated investment managers.

IRS Internal Revenue Bulletin 2026-13

The IRS published Internal Revenue Bulletin 2026-13, including proposed regulations on electronic furnishing of payee statements for digital asset sales by brokers and guidance on a new pilot program for child accounts. The bulletin also includes a notice requesting comments on modifying electronic furnishing requirements for brokers and other persons.

Digital Euro Benefits and Pilot Plans

The European Central Bank (ECB) outlined the benefits and pilot plans for a digital euro, emphasizing its role in enhancing European payment autonomy and resilience. A 12-month pilot program is scheduled to begin in the second half of 2027, involving selected payment service providers, merchants, and Eurosystem staff.

DEA Schedules 3-MeO-PCP as Schedule I Controlled Substance

The Drug Enforcement Administration (DEA) has finalized a rule placing 3-methoxyphencyclidine (3-MeO-PCP) into Schedule I of the Controlled Substances Act. This action classifies the substance as having a high potential for abuse and no currently accepted medical use in treatment in the United States.

Court Grants Summary Judgment for Ryan Homes in Bravos Case

The Delaware Superior Court granted summary judgment for NVR, Inc. t/a Ryan Homes in a case filed by Dr. Emmanuel D. Bravos. The court found that the plaintiff's claims were time-barred by a one-year limitations period stipulated in the purchase agreement.

Medical Board Decision Affirmed in Part, Reversed, Remanded

The Delaware Superior Court reviewed a decision by the Delaware Board of Medical Licensure and Discipline concerning Dr. Jane Williams-Moore. The court affirmed parts of the Board's order but reversed and remanded two specific provisions related to disclosure requirements and automatic license revocation.

Deckers Outdoor Corporation v. Last Brand, Inc. - Corrected Pretrial Memorandum

Last Brand, Inc. has filed a corrected pretrial memorandum in the trademark infringement case Deckers Outdoor Corporation v. Last Brand, Inc. The filing on March 18, 2026, corrects a previous submission, indicating ongoing procedural activity in the litigation.